{
    "paper_id": "PMC7186112",
    "metadata": {
        "title": "Coronavirus disease 2019 and obstructive sleep apnea syndrome",
        "authors": [
            {
                "first": "Ahmet",
                "middle": [
                    "Cemal"
                ],
                "last": "Pazarl\u0131",
                "suffix": "",
                "email": "dracp60@gmail.com",
                "affiliation": {}
            },
            {
                "first": "Timur",
                "middle": [],
                "last": "Ekiz",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Faik",
                "middle": [],
                "last": "\u0130lik",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Dear Editor",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The publications regarding the continuing of pandemic coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing. Increased age, hypertension, cardiovascular diseases, lung diseases, and diabetes mellitus seem to be the main risk factors for mortality in COVID-19 [1]. However, the possible association between obstructive sleep apnea syndrome (OSAS), repetitive airway collapse with apnea/hypopnea and hypoxia during sleep, and COVID-19 has not been reported yet.",
            "cite_spans": [
                {
                    "start": 330,
                    "end": 331,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Angiotensin converting enzyme 2 (ACE2) is the entry receptor of SARS-CoV-2 [2]. Of note, the increased expression of ACE and dysregulation of renin angiotensin system in untreated OSAS patients due to chronic intermittent hypoxia has been shown [3]. Furthermore, cardiovascular complications or comorbidities such as hypertension, heart failure, coronary artery disease, cerebrovascular diseases, diabetes mellitus, and obesity\u2014those are also risk factors for mortality in COVID-19\u2014are commonly seen in OSAS patients [1, 4]. Fibrotic changes can also be seen after COVID-19 [5] and fibrosis was peviously shown to be a risk factor for OSAS.",
            "cite_spans": [
                {
                    "start": 76,
                    "end": 77,
                    "mention": "2",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 246,
                    "end": 247,
                    "mention": "3",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 518,
                    "end": 519,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 521,
                    "end": 522,
                    "mention": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 575,
                    "end": 576,
                    "mention": "5",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "To the best of our knowledge, this is one of the first reports highlighting the possible association between OSAS and COVID-19. Herewith, presenting this clinical perspective is two-fold. First, OSAS may be a risk factor for mortality or deteriorate the clinical scenario in COVID-19. Therefore, keeping in mind the modulating effects of sleep on the immune system, proper treatment of OSAS patients may be protective/beneficial in COVID-19. Second, patients who suffered from COVID-19, particularly severe cases, may be under risk for OSAS due to pulmonary fibrosis. Clinicians should be cautious against the OSAS presence during the later periods in relevant patients.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "10229",
            "pages": "1054-1062",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30566-3"
                ]
            }
        },
        "BIBREF1": {
            "title": "COVID-19, ACE2 and the cardiovascular consequences",
            "authors": [
                {
                    "first": "AM",
                    "middle": [],
                    "last": "South",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Diz",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Chappell",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Physiol Heart Circ Physiol",
            "volume": "318",
            "issn": "",
            "pages": "H1084-H1090",
            "other_ids": {
                "DOI": [
                    "10.1152/ajpheart.00217.2020.(inpress)"
                ]
            }
        },
        "BIBREF2": {
            "title": "Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Barcel\u00f3",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Elorza",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Barb\u00e9",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Santos",
                    "suffix": ""
                },
                {
                    "first": "LR",
                    "middle": [],
                    "last": "Mayoralas",
                    "suffix": ""
                },
                {
                    "first": "AGN",
                    "middle": [],
                    "last": "Agust\u00ed",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Eur Respir J",
            "volume": "17",
            "issn": "4",
            "pages": "728-732",
            "other_ids": {
                "DOI": [
                    "10.1183/09031936.01.17407280"
                ]
            }
        },
        "BIBREF3": {
            "title": "Comorbidities associated with obstructive sleep apnea: a retrospective study",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Pinto",
                    "suffix": ""
                },
                {
                    "first": "DK",
                    "middle": [],
                    "last": "Ribeiro",
                    "suffix": ""
                },
                {
                    "first": "AF",
                    "middle": [],
                    "last": "Cavallini",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Duarte",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Freitas",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int Arch Otorhinolaryngol",
            "volume": "20",
            "issn": "2",
            "pages": "145-150",
            "other_ids": {
                "DOI": [
                    "10.1055/s-0036-1579546"
                ]
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}